What can patients with atopic dermatitis expect in terms of long-term efficacy and sustained symptom control with lebrikizumab treatment?

Featuring Mona Shahriari, MD | Associate Clinical Professor of Dermatology, Yale University; Associate Director of Clinical Trials, Central CT Dermatology Research, Cromwell, CT | Published November 06, 2024